BeStock  
Stocks › Biotechnology › LBRX

LB Pharmaceuticals LBRX

US equityMarket cap rank #3009Biotechnology
$38.85 −$1.19 (-2.97%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $38.85 0.00%
Open$39.53
Prev close$40.04
Day range$38.57 – $40.67
Volume303.1K
Market cap$1.26B
P/E (TTM)38.3
Dividend yield–

Analyst view

ConsensusBuy
Analysts8
Average target$65.88+69.6% vs. price
  • Buy 100%
Low $53.00Now $38.85Avg $65.88High $80.00

Recent rating changes

The last 20 actions on file set price targets from $53.00 to $80.00, averaging $68.35.

DateFirmRatingTarget
12 Nov 2026 Guggenheim BUY $80.00
9 Nov 2026 H.C. Wainwright BUY $60.00
6 Nov 2026 CCORF BUY $65.00
6 Nov 2026 Piper Sandler BUY $78.00
5 Nov 2026 BMO Capital BUY $54.00
5 Nov 2026 Guggenheim BUY $80.00
2 Nov 2026 Piper Sandler BUY $78.00
2 Nov 2026 H.C. Wainwright BUY $60.00
28 Oct 2026 CCORF BUY $65.00
28 Oct 2026 Piper Sandler BUY $78.00
28 Oct 2026 Guggenheim BUY $80.00
27 Oct 2026 BMO Capital BUY $54.00
21 Oct 2026 Stifel BUY $53.00
12 Oct 2026 Guggenheim BUY $80.00
12 Oct 2026 H.C. Wainwright BUY $60.00
9 Oct 2026 CCORF BUY $65.00
5 Oct 2026 Guggenheim BUY $80.00
2 Oct 2026 Needham BUY $68.00
24 Aug 2026 H.C. Wainwright BUY $60.00
21 Aug 2026 Clear Street BUY $69.00

Discussion

No comments yet — be the first to weigh in on LBRX.

Sign in to join the discussion.

Scroll to Top